Lance Liotta
Overview
Explore the profile of Lance Liotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1917
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Baldelli E, Alex Hodge K, Bellezza G, Shah N, Gambara G, Sidoni A, et al.
J Immunother Cancer
. 2021 Oct;
9(10).
PMID: 34620701
Background: Anti-programmed cell death protein 1 and programmed cell death ligand 1 (PD-L1) agents are broadly used in first-line and second-line treatment across different tumor types. While immunohistochemistry-based assays are...
12.
13.
Damluji A, Wei S, Bruce S, Haymond A, Petricoin E, Liotta L, et al.
Lancet Reg Health Am
. 2021 Aug;
2:100030.
PMID: 34386793
Background: Because of their direct patient contact, healthcare workers (HCW) face an unprecedented risk of exposure to COVID-19. The aim of this study was to examine incidence of COVID-19 disease...
14.
Haymond A, Damluji A, Narayanan A, Mueller C, Reeder A, Alem F, et al.
J Infect Dis
. 2021 Mar;
223(10):1677-1680.
PMID: 33718952
A cohort consisting of asymptomatic healthcare workers donated temporal serum samples after infection with severe acute respiratory syndrome coronavirus 2. Analysis shows that all asymptomatic healthcare workers had neutralizing antibodies,...
15.
Yaegashi M, Iwaya T, Sasaki N, Fujita M, Ju Z, Siwak D, et al.
Br J Cancer
. 2021 Mar;
124(9):1556-1565.
PMID: 33658639
Background: Circulating tumour DNA (ctDNA) is known as a tumour-specific personalised biomarker, but the mutation-selection criteria from heterogeneous tumours remain a challenge. Methods: We conducted multiregional sequencing of 42 specimens...
16.
Fredolini C, Pathak K, Paris L, Chapple K, Tsantilas K, Rosenow M, et al.
Breast Cancer Res
. 2020 Dec;
22(1):135.
PMID: 33267867
Background: The lack of specificity and high degree of false positive and false negative rates when using mammographic screening for detecting early-stage breast cancer is a critical issue. Blood-based molecular...
17.
Collins D, Madden S, Gaynor N, Alsultan D, Le Gal M, Eustace A, et al.
Clin Cancer Res
. 2020 Oct;
27(3):807-818.
PMID: 33122343
Purpose: Antibody-dependent cell-mediated cytotoxicity (ADCC) is one mechanism of action of the monoclonal antibody (mAb) therapies trastuzumab and pertuzumab. Tyrosine kinase inhibitors (TKIs), like lapatinib, may have added therapeutic value...
18.
Carter R, Luchini A, Liotta L, Haymond A
Curr Pathobiol Rep
. 2020 Oct;
7(3):61-71.
PMID: 33094031
Purpose Of Review: We discuss recent advancements in structural biology methods for investigating sites of protein-protein interactions. We will inform readers outside the field of structural biology about techniques beyond...
19.
Haymond A, Mueller C, Steinberg H, Alex Hodge K, Lehman C, Lin S, et al.
medRxiv
. 2020 Aug;
PMID: 32766594
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), became a pandemic in early 2020. Lateral flow immunoassays for antibody testing have been viewed as a...
20.
Magni R, Luchini A, Liotta L, Molestina R
Parasitol Res
. 2020 May;
119(7):2227-2235.
PMID: 32435898
Babesiosis among humans is on the rise in North America. Current diagnostic assays for the screening of babesiosis require blood collection by venipuncture, which is an invasive method. Urine on...